Literature DB >> 10232579

HRad17, a human homologue of the Schizosaccharomyces pombe checkpoint gene rad17, is overexpressed in colon carcinoma.

S Bao1, M S Chang, D Auclair, Y Sun, Y Wang, W K Wong, J Zhang, Y Liu, X Qian, R Sutherland, C Magi-Galluzi, E Weisberg, E Y Cheng, L Hao, H Sasaki, M S Campbell, S K Kraeft, M Loda, K M Lo, L B Chen.   

Abstract

Using the palindromic PCR-cDNA display method, we have cloned a novel gene overexpressed by human colon carcinoma relative to normal colon. Among normal tissues examined, only testis expresses it at a high level. Sequence analysis revealed its extensive homology with checkpoint genes rad17 of Schizosaccharomyces pombe and RAD24 of Saccharomyces cerevisiae. This novel gene designated as hRad17 is localized to chromosome 5q12,13.1, a region known to be deleted in a variety of human cancers. Promoter region and one pseudogene of hRad17 have been identified. Whereas the increased expression of hRad17 by human colon carcinomas may be related to the known resistance of these cells to DNA-damaging agents during therapy, the deletion of hRad17 in a variety of cancers may predispose them to increased rate of mutation and heightened sensitivity to DNA-damaging agents, including radiation and anticancer drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10232579

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Regulation of Rad17 protein turnover unveils an impact of Rad17-APC cascade in breast carcinogenesis and treatment.

Authors:  Zhuan Zhou; Chao Jing; Liyong Zhang; Fujita Takeo; Hyun Kim; Yi Huang; Zhihua Liu; Yong Wan
Journal:  J Biol Chem       Date:  2013-05-01       Impact factor: 5.157

2.  Rad17 recruits the MRE11-RAD50-NBS1 complex to regulate the cellular response to DNA double-strand breaks.

Authors:  Qinhong Wang; Michael Goldstein; Peter Alexander; Timothy P Wakeman; Tao Sun; Junjie Feng; Zhenkun Lou; Michael B Kastan; Xiao-Fan Wang
Journal:  EMBO J       Date:  2014-02-16       Impact factor: 11.598

3.  Phosphorylation of serines 635 and 645 of human Rad17 is cell cycle regulated and is required for G(1)/S checkpoint activation in response to DNA damage.

Authors:  S Post; Y C Weng; K Cimprich; L B Chen; Y Xu; E Y Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

Review 4.  Aneuploidy and malignancy: an unsolved equation.

Authors:  P Dey
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

5.  The human checkpoint Rad protein Rad17 is chromatin-associated throughout the cell cycle, localizes to DNA replication sites, and interacts with DNA polymerase epsilon.

Authors:  Sean M Post; Alan E Tomkinson; Eva Y-H P Lee
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

6.  Genetic polymorphism at codon 546 of the human RAD17 contributes to the risk for esophageal squamous cell carcinoma.

Authors:  Yukiko Yasuda; Akiko Sakai; Sachio Ito; Yuichiro Mita; Takayuki Sonoyama; Shunsuke Tanabe; Yasuhiro Shirakawa; Yoshio Naomoto; Hiroshi Katayama; Kenji Shimizu
Journal:  Int J Mol Epidemiol Genet       Date:  2016-03-23

7.  Hrad17 expression in thymoma.

Authors:  Hidefumi Sasaki; Yoshihiro Kobayashi; Haruhiro Yukiue; Motoki Yano; Masahiro Kaji; Ichiro Fukai; Masanobu Kiriyama; Yosuke Yamakawa; Yoshitaka Fujii
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-03

Review 8.  Genomic and epigenetic instability in colorectal cancer pathogenesis.

Authors:  William M Grady; John M Carethers
Journal:  Gastroenterology       Date:  2008-09-04       Impact factor: 22.682

9.  Differential hRad17 expression by histologic subtype of ovarian cancer.

Authors:  Jennifer L Young; E Colin Koon; Joseph Kwong; William R Welch; Michael G Muto; Ross S Berkowitz; Samuel C Mok
Journal:  J Ovarian Res       Date:  2011-03-30       Impact factor: 4.234

10.  Biological and functional analysis of statistically significant pathways deregulated in colon cancer by using gene expression profiles.

Authors:  Angela Distaso; Luca Abatangelo; Rosalia Maglietta; Teresa Maria Creanza; Ada Piepoli; Massimo Carella; Annarita D'Addabbo; Nicola Ancona
Journal:  Int J Biol Sci       Date:  2008-10-14       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.